rs1057854

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBP6_Very_Strong

The NM_000085.5(CLCNKB):​c.*271G>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.33 ( 224 hom., cov: 41)
Exomes 𝑓: 0.28 ( 114 hom. )
Failed GnomAD Quality Control

Consequence

CLCNKB
NM_000085.5 3_prime_UTR

Scores

1
11

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -3.23

Publications

10 publications found
Variant links:
Genes affected
CLCNKB (HGNC:2027): (chloride voltage-gated channel Kb) The protein encoded by this gene is a member of the family of voltage-gated chloride channels. Chloride channels have several functions, including the regulation of cell volume, membrane potential stabilization, signal transduction and transepithelial transport. This gene is expressed predominantly in the kidney and may be important for renal salt reabsorption. Mutations in this gene are associated with autosomal recessive Bartter syndrome type 3 (BS3). Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2009]
CLCNKB Gene-Disease associations (from GenCC):
  • Bartter disease type 3
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
  • Bartter disease type 4B
    Inheritance: AR Classification: STRONG Submitted by: G2P
  • Bartter syndrome type 4
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Gitelman syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0025365949).
BP6
Variant 1-16057187-G-C is Benign according to our data. Variant chr1-16057187-G-C is described in ClinVar as Benign. ClinVar VariationId is 402540.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CLCNKBNM_000085.5 linkc.*271G>C 3_prime_UTR_variant Exon 20 of 20 ENST00000375679.9 NP_000076.2 P51801-1A8K8H0
CLCNKBNM_001165945.2 linkc.*271G>C 3_prime_UTR_variant Exon 13 of 13 NP_001159417.2 P51801-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CLCNKBENST00000375679.9 linkc.*271G>C 3_prime_UTR_variant Exon 20 of 20 1 NM_000085.5 ENSP00000364831.5 P51801-1

Frequencies

GnomAD3 genomes
AF:
0.329
AC:
46820
AN:
142470
Hom.:
223
Cov.:
41
show subpopulations
Gnomad AFR
AF:
0.407
Gnomad AMI
AF:
0.259
Gnomad AMR
AF:
0.259
Gnomad ASJ
AF:
0.273
Gnomad EAS
AF:
0.438
Gnomad SAS
AF:
0.292
Gnomad FIN
AF:
0.277
Gnomad MID
AF:
0.367
Gnomad NFE
AF:
0.302
Gnomad OTH
AF:
0.334
GnomAD2 exomes
AF:
0.298
AC:
41736
AN:
140152
AF XY:
0.301
show subpopulations
Gnomad AFR exome
AF:
0.402
Gnomad AMR exome
AF:
0.218
Gnomad ASJ exome
AF:
0.289
Gnomad EAS exome
AF:
0.424
Gnomad FIN exome
AF:
0.292
Gnomad NFE exome
AF:
0.304
Gnomad OTH exome
AF:
0.301
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR;InbreedingCoeff
AF:
0.275
AC:
126136
AN:
458492
Hom.:
114
Cov.:
0
AF XY:
0.277
AC XY:
69246
AN XY:
250084
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.383
AC:
5023
AN:
13108
American (AMR)
AF:
0.213
AC:
6394
AN:
30082
Ashkenazi Jewish (ASJ)
AF:
0.249
AC:
4139
AN:
16646
East Asian (EAS)
AF:
0.405
AC:
9328
AN:
23020
South Asian (SAS)
AF:
0.285
AC:
16287
AN:
57194
European-Finnish (FIN)
AF:
0.257
AC:
10206
AN:
39642
Middle Eastern (MID)
AF:
0.288
AC:
992
AN:
3440
European-Non Finnish (NFE)
AF:
0.267
AC:
66989
AN:
251300
Other (OTH)
AF:
0.282
AC:
6778
AN:
24060
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.346
Heterozygous variant carriers
0
6399
12797
19196
25594
31993
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
472
944
1416
1888
2360
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Data not reliable, filtered out with message: InbreedingCoeff
AF:
0.329
AC:
46847
AN:
142580
Hom.:
224
Cov.:
41
AF XY:
0.326
AC XY:
22729
AN XY:
69680
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.407
AC:
15910
AN:
39062
American (AMR)
AF:
0.258
AC:
3699
AN:
14324
Ashkenazi Jewish (ASJ)
AF:
0.273
AC:
896
AN:
3282
East Asian (EAS)
AF:
0.439
AC:
2082
AN:
4746
South Asian (SAS)
AF:
0.291
AC:
1280
AN:
4406
European-Finnish (FIN)
AF:
0.277
AC:
2762
AN:
9956
Middle Eastern (MID)
AF:
0.358
AC:
96
AN:
268
European-Non Finnish (NFE)
AF:
0.302
AC:
19248
AN:
63722
Other (OTH)
AF:
0.333
AC:
653
AN:
1960
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.380
Heterozygous variant carriers
0
1975
3950
5926
7901
9876
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
552
1104
1656
2208
2760
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.319
Hom.:
21
ExAC
AF:
0.224
AC:
5374

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: ExAC frequency -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.16
BayesDel_addAF
Benign
-0.48
T
BayesDel_noAF
Benign
-0.92
CADD
Benign
0.024
DANN
Benign
0.31
Eigen
Benign
-1.3
Eigen_PC
Benign
-1.6
FATHMM_MKL
Benign
0.0070
N
LIST_S2
Benign
0.27
T
MetaRNN
Benign
0.0025
T
MetaSVM
Benign
-0.98
T
PhyloP100
-3.2
Sift4G
Uncertain
0.0090
D
Vest4
0.090
ClinPred
0.0074
T
GERP RS
-4.9
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1057854; hg19: chr1-16383682; COSMIC: COSV65152876; COSMIC: COSV65152876; API